Weight-bearing in the first two weeks

For the first two weeks after a ChondroFiller® knee injection, the joint needs protection from full compressive load. That means walking with crutches and wearing a brace — not because the injection created a wound that needs to heal, but because the collagen scaffold must stabilise mechanically within the cartilage defect before it can tolerate the forces of normal gait.

The gel itself sets within three to five minutes of being placed under ultrasound guidance. What has not yet started at that point is the biological phase: stem cells and progenitor cells migrating from the surrounding tissue into the scaffold, a process that takes days to weeks to get properly under way. Until that cell ingrowth begins to anchor the material, compressive and shearing forces from full weight-bearing could displace or disrupt the scaffold before it has had the chance to integrate.

Crutches and a brace reduce those forces during this critical window. Most patients manage light day-to-day movement — brief walking, sitting, getting in and out of a car — within the first week, but sustained standing, stair-climbing, and any activity that loads the knee repeatedly should remain restricted.

A follow-up consultation, included in the treatment package and typically occurring within the first six weeks, is the point at which the treating clinician assesses how the joint is responding and determines whether weight-bearing can be safely progressed. The pace of that progression is individual — it reflects the size of the defect, the baseline condition of the joint, and how the tissue is responding — rather than a fixed calendar date.

The four phases from injection to full activity

Recovery from a ChondroFiller® knee injection follows four broadly sequential phases, each timed to what the scaffold is doing biologically rather than simply to how the knee feels.

The four phases at a glance

Phase 1 — Protect (around weeks 1–6) As established above, weight-bearing remains restricted during this period while the scaffold stabilises and begins recruiting the patient's own progenitor cells from the surrounding tissue. Gentle range-of-motion exercises may be introduced early, but the priority throughout is shielding the gelling material from mechanical disruption before cell ingrowth takes hold.

Phase 2 — Strengthen (around weeks 6–12) Once early cell ingrowth is under way, physiotherapy shifts towards rebuilding muscle strength and joint stability. Cycling and swimming are typically introduced during this window because they load the knee progressively without the impact peaks of running. High-impact activity remains off limits — the repair tissue is forming, but it is not yet dense or integrated enough to tolerate those forces.

Phase 3 — Functional Loading (approximately months 2–6) Jogging is generally introduced during this phase, alongside sport-specific movement drills under physiotherapist supervision. The guiding principle is progressive load matched to tissue maturation: the acellular scaffold is supporting the body's own repair processes, and that consolidation takes time — advancing too quickly risks disrupting repair tissue that is still developing.

Phase 4 — Return to Sport (months 6–12) Full activity, including high-impact sport, typically becomes possible within this window as structural repair matures. MRI evidence from ChondroFiller® knee studies confirms that repair tissue continues to improve throughout the first year, which is precisely why this phase is not reached until the later part of that arc rather than at the first sign of symptomatic improvement.

Progression between phases is clinician-led rather than self-directed. Symptom relief alone is not a reliable indicator that the scaffold has matured sufficiently: a patient may feel comfortable well before the repair tissue is ready for heavier loads, and moving ahead of the tissue risks undoing what the preceding phases protected.

Physiotherapy during weeks 6 to 12

Muscle strength around the knee drops measurably in the weeks following any significant joint procedure, and that loss matters beyond comfort: the quadriceps and hip abductors act as dynamic stabilisers that shield the joint surfaces from asymmetric load. During weeks six to twelve, supervised physiotherapy focuses on rebuilding this muscular support so that the maturing scaffold is not asked to bear forces it cannot yet distribute safely.

The muscle groups prioritised at this stage are the quadriceps — particularly the vastus medialis oblique, which provides medial tracking control — and the hip abductors, whose function directly affects the alignment of load across the knee with every step. Weakness in either group transmits disproportionate stress to the medial or lateral compartment, exactly the areas where repair tissue is most vulnerable during consolidation. The specific exercises and loading progression are determined by a physiotherapist working in coordination with the treating consultant, not by a fixed timetable: because cartilage repair proceeds at an individual pace, the programme is constructed around how the joint is actually responding rather than the calendar.

Low-impact aerobic work is introduced progressively within this window. Stationary cycling allows a controlled range of knee flexion under minimal axial load; swimming removes bodyweight from the joint almost entirely while maintaining cardiovascular conditioning and lower-limb muscle activity. Both are suited to this phase because they challenge the joint enough to stimulate tissue remodelling without the repetitive impact peaks of running, which remain off limits until the repair tissue is denser and better integrated.

Swelling remains the primary safety signal throughout weeks six to twelve. An increase in effusion after any strength session or aerobic activity indicates that load has advanced faster than the repair tissue can currently tolerate. Scaling back rather than pushing through is the appropriate response — persistent effusion at this stage is not a sign of failure, but it is a clear instruction to slow the programme down.

When running and sport can safely resume

The question most active patients bring to their first post-procedure appointment is a simple one: when can I run again? The honest answer is not before around months two to three at the earliest — and for high-impact or contact sport, the realistic window is months six to twelve.

Jogging is typically introduced during the Functional Loading phase, from approximately month two through to month six. By that point the scaffold has had several weeks of strengthening support, and repair tissue is consolidating — but it is not yet structurally mature. The introduction of jogging is therefore supervised and progressive, beginning with short, flat runs before advancing to speed work or uneven ground. Sport-specific demands such as cutting, pivoting, and impact loading are deferred further: these place multidirectional stress on maturing repair tissue that is not appropriate until structural integration is more advanced, typically from around month six onwards.

This timetable is biological rather than arbitrary. Structural repair tissue matures progressively across the full twelve-month arc post-injection, and the scaffold supports a process that does not complete quickly. A patient may feel comfortable jogging at month three without the underlying repair being ready for the repetitive loading of weekly match play — symptomatic improvement alone is an unreliable guide to sport-readiness.

Because no single published protocol covers return-to-sport timing for the injection route, the assessment is made individually by the treating clinician, shaped by defect size, surrounding joint condition, and how rehabilitation has progressed. Patients with Kellgren-Lawrence Grade III/IV osteoarthritis should also approach activity expectations differently from those with focal defects in an otherwise healthy knee: for the OA group, the goal is often sustainable low-impact activity rather than a return to competitive sport, and a frank conversation about realistic longer-term activity goals is part of planning recovery from the outset.

How cartilage repair progresses on MRI

Feeling better and being structurally ready are not the same thing — and MRI is how clinicians distinguish between the two.

MOCART is the imaging score used to track cartilage repair quality on MRI. It runs from 0 to 100 and captures several properties at once: how completely the defect has filled with new tissue, how smoothly that tissue integrates with the surrounding cartilage, how homogeneous the signal appears (a proxy for tissue maturity), and whether the underlying subchondral bone remains intact. A score of 80 or above indicates the defect is largely filled with well-integrated repair tissue.

The figures cited earlier in this article — around 65 at four weeks, rising to 81–84 by twelve months — trace a process that does not pause when symptoms improve. The collagen scaffold that initially gives the repair site its shape is progressively resorbed and replaced by the patient's own repair tissue across the first year. By month twelve, the scaffold is no longer the structural element; the cells it recruited have done that work. Consolidation continues into years one and two as repair tissue matures further.

The practical consequence is that a patient who feels comfortable jogging at month three may still carry a MOCART score in the high 60s — meaningful early fill, but not yet the integration quality that sustained loading demands. Symptom relief and structural maturation follow different timelines, and they do not always converge at the same point. Imaging-guided milestone assessments allow the treating clinician to match activity clearance to the biological clock rather than to how the knee feels on a given day.

What outcomes patients typically report

The functional data from published ChondroFiller® knee studies give those timelines concrete shape. Across four clinical studies, patients showed IKDC score improvements consistently exceeding the minimal clinically important difference of 16.7 points. The Jerosch et al. post-market clinical follow-up study recorded a mean improvement of 32.4 IKDC points, with participants reaching an average functional score of 80.1 at three-year follow-up — broadly equivalent to comfortable participation in everyday physical activity and moderate sport. Crucially, that improvement held and edged slightly higher between the one-year and three-year assessments, indicating durable rather than short-term benefit.

Comparative collagen injection data add context. Studies of hydrolysed collagen knee injections reported 56% improvement in WOMAC total score and 52% pain reduction at twelve months, significantly outperforming hyaluronic acid (22.5% and 16% respectively, p<0.05). These figures come from a different preparation and patient group, but reinforce the biological rationale that collagen-based scaffold treatment can produce meaningful, sustained functional gains in the knee.

Timing matters when interpreting these numbers. Meaningful functional gains from scaffold-based cartilage repair can be evident within three months; structural maturation — and the maximal functional benefit that follows — continues across the full twelve to twenty-four months. A patient who notices real improvement at month four is not at the endpoint.

Individual results vary with defect size, cartilage grade, patient age, and adherence to the phased rehabilitation programme. Post-market clinical follow-up data record a complaint rate of approximately 0.06% for ChondroFiller®, supporting a favourable safety profile alongside the functional outcomes.

The picture that emerges across this recovery guide is of a treatment whose timeline is biological: a scaffold recruiting the body's own repair cells, maturation unfolding progressively over months, and functional gains that are sustained when each rehabilitation phase is respected. Determining whether this pathway suits a specific defect and activity goal is the work of a clinical assessment. Lincolnshire Knee, part of the MSK Doctors group, accepts patients without referral — book at lincolnshireknee.co.uk.

1. [1] Efficacy of hydrolyzed collagen injections compared to platelet-rich plasma and hyaluronic acid in symptomatic knee osteoarthritis. (2025). https://doi.org/10.1186/s12891-025-08811-9 https://doi.org/10.1186/s12891-025-08811-9
2. [2] Treatment of Large Cartilage Defects in the Knee by Hydrogel-Based Autologous Chondrocyte Implantation: A 5-Year Follow-Up of a Prospective, Multicenter, Single-Arm Phase III Trial. (2025). https://doi.org/10.1177/19476035251334737 https://doi.org/10.1177/19476035251334737
3. [3] Clinical Efficacy and Safety of Two Cycles of Intra-Articular Injection of Porcine Atelocollagen Versus Hyaluronic Acid in Knee Osteoarthritis. (2025). https://doi.org/10.3390/bioengineering12070710 https://doi.org/10.3390/bioengineering12070710